These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18612800)

  • 1. CD133 identifies perivascular niches in grade II-IV astrocytomas.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133+ niches and single cells in glioblastoma have different phenotypes.
    Christensen K; Schrøder HD; Kristensen BW
    J Neurooncol; 2011 Aug; 104(1):129-43. PubMed ID: 21184132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
    He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
    Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
    Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
    Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
    Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
    Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
    Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glial stem cells and their relationship with tumour angiogenesis process].
    Bulnes S; García-Blanco Á; Bengoetxea H; Ortuzar N; Argandoña EG; Lafuente JV
    Rev Neurol; 2011 Jun; 52(12):743-50. PubMed ID: 21594859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
    PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas.
    Jensen SS; Aaberg-Jessen C; Christensen KG; Kristensen B
    Int J Clin Exp Pathol; 2013; 6(7):1294-305. PubMed ID: 23826410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.
    Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
    Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
    Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
    Hlobilkova A; Ehrmann J; Knizetova P; Krejci V; Kalita O; Kolar Z
    Neoplasma; 2009; 56(4):284-90. PubMed ID: 19473053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.